InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,131.60
(
-0.23%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.38
(
-0.11%
)
Bitcoin
60,805.77
(
-0.01%
)
Post# of 252389
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

apljack

Send PM Follow Ignore
Followers 6
Posts 703
Boards Moderated 0
Alias Born 09/23/2006

apljack

Re: DewDiligence post# 135561

Tuesday, 01/24/2012 10:09:58 AM

Tuesday, January 24, 2012 10:09:58 AM

Post# of 252389
NGNM…and some interest from both ABT and Quest regarding this test on the side

From the HDVY press release dated 11/14/11

"Quest Diagnostics (NYSE:DGX) has acquired a Non-Exclusive royalty based license for the laboratory developed test (LDT) version of the HDC urine based four gene prostate cancer test. HDC continues to have discussions with other clinical laboratories interested in licensing the LDT version of its urine prostate cancer test.

Abbott (NYSE:ABT) has acquired a worldwide Exclusive royalty based license to develop an in-vitro diagnostic test kit for the HDC urine prostate cancer test."

http://www.healthdiscoverycorp.com/pr/oct14_11.html

aj
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up